Company Overview

Update
Founded:
2007
Headquarters:
New Providence, NJ
Funding:
$74.6M
Categories:
Health Care
Description:
Svelte Medical Systems delivers novel products in the coronary stent market to curb key clinical issues by improving stent deliverability.

Detailed Description

Update

Svelte Medical Systems, Inc. (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Svelte was founded in 2007 by Robert Fischell, ScD, David Fischell, PhD and Tim Fischell, MD with a mission to address key clinical issues in the stent market by improving stent deliverability, reducing cost and dramatically improving the safety of the device compared to currently market products.

Svelte has developed the lowest profile and most deliverable balloon expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug Eluting Stent (DES).

Current Team (6)

Update

Funding Rounds (8) - $74.6M

Update

Board Members and Advisors (6)

Update

Investors (4)

Update

Offices/Locations (3)

Update
  • Latin America

    Av. Juscelino Kubitschek

    no 28, cj. 32 / Itaim, Bibi

    São Paulo,

    BRA

  • Europe

    Rue des Colonies - Koloniënstraat, 11 Room 1.11

    1000 Brussels

    Grendel,

    GBR

  • North America

    675 Central Avenue

    New Providence, NJ 07974

    USA

Images (1)

Update
  • 3ed582cf36e7fab6be2d8b73455840be